To assess the functional relevance of cross-presenting cDC1 in IL-32–induced tumor control, we examined the effects of IL-32 treatment in B16F10 tumors inoculated in Batf3–/– mice according to the established treatment regimen (see Figure 4A). This evidence concerns the gene MPPE1 and neoplasm.